StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Raised to $125 at Credit Suisse; Raise Probability of Triplet to 75%
April 28, 2017 6:26 AM
Credit Suisse raised its price target on Vertex (NASDAQ: VRTX) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
FDA
Next Articles
Vertex Pharma (VRTX) Tops Q1 EPS by 1c
April 27, 2017 4:18 PM
Vertex Reports First-Quarter 2017 Financial Results
April 27, 2017 4:01 PM
Moderna Announces Positive Interim Phase 1 Clinical Data Demonstrating First mRNA Vaccine Candidate, mRNA-1440, Induces High Levels of Immunogenicity
April 27, 2017 12:00 PM